Found: 2
Select item for more details and to access through your institution.
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2512, doi. 10.3390/cancers16142512
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer: Impact of Tumor Ki67 and ER Status.
- Published in:
- Chemotherapy (0009-3157), 2024, v. 69, n. 3, p. 141, doi. 10.1159/000537874
- By:
- Publication type:
- Article